Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients

Clinical trial NCT05899608 · RECRUITING

Trial details

NCT number: NCT05899608
Sponsor: Summit Therapeutics
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2023-10-26
Primary completion: 2028-12-31
Enrollment: 1600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.